We use cookies to enhance your browsing experience and analyze site traffic. By continuing to use this site, you agree to our cookie policy. Privacy Policy
Updates on new features, capability upgrades, and platform experience improvements.
The new AI antibody R&D collaboration platform is now officially launched. Built around project spaces, research goals, and AI agent interactions, the platform enables individual researchers and teams to conduct antibody design, analysis, and collaboration through natural language. It provides several core antibody R&D capabilities, including:
The platform also supports structured management and visualization of computational results, including antibody sequence analysis, structural model display, and design result comparison, helping researchers better understand computational outputs and advance subsequent research.